IntellicapIntellicap
HomeTracker
IntellicapIntellicap

Intellectual Capital

  • What is IC?
  • IC Reporting
  • Investing Insights
  • IC News

Tools

  • icTracker
  • icTopTen
  • icFunding
  • icValue

Services

  • icAdvisor India
  • icAdvisor USA
  • MF Advisor
  • Financial Planner

Company

  • About Us
  • Contact Us
  • Investor Charter
  • Terms of Use

Copyright © 2007-2026 Intellicap - All rights reserved.

Alivus Life Sciences

PharmaceuticalsBSE: 543322NSE: ALIVUS
ISININE03Q201024
FreeFloat17.16%
FnONo
Lot Size0

Indices containing this Stock

Valuation

Rs. Cr

Intellectual Capital (IC)

4,662.78

Rs. Cr

Net Worth (NW)

3,165.62

Rs. Cr

Intrinsic Worth (IW)

7,828.40

Rs. Cr

Market Cap (MC)

11,244.97

Rs. Cr

Economic Value Added

64.41

Rs. Cr

IC Ratios

Knowledge Basis (IC/IW)

59.56%

IC Gross Margin (EBITDA/IC)

17.34%

IC Net Margin (NPT/IC)

11.17%

Knowledge Turnover (Sales/IC)

Stock Price

Intrinsic ValueRs. 638.11As of 2025-12-31
Premium+46.7%
Market PriceRs. 936.10
2026-03-1710.65 (1.14%)

Stock Sentimeter

Sentimeter is based on market data calculations and is NOT an investment advice

Fundamental - Quality

  • EVA > 0:Yes
  • KB > 50%:Yes
  • 0 < M2IV < 1:No

Technical - Daily Price Action

  • 10 DMARs. 929.20
  • 50 DMARs. 911.77
  • Vol-Price trendRising

Near-term Outlook

Very Bullish

Analysis Charts

Is this stock undervalued?

Intrinsic Value vs Book Value vs Market Price over Time

Does this business have significant knowledge assets?

Knowledge Basis over Time

Is this business generating enough profits?

EVA over Time

Quarterly Results

Rs. Cr | * C - Consolidated, S - Standalone

QuarterType*SalesIncomeEBITDAEBITPBTPATNPT
Mar-23S621624209198198146146
Jun-23S578580195182182135
  1. Registration granted by SEBI, membership of BASL and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.
  2. Past performance, by way of backtesting or by way of actuals, is no guarantee of future returns.
  3. Data mentioned on this page is for educational purpose only and does not constitute investment advice.

Standard Warning - Investment in securities markets are subject to market risk. Read all the related documents carefully before investing.

0.54

Market to IV (MC/IW)

1.44

135
Sep-23S595601172159159119119
Dec-23S573575174161161119119
Mar-24S5375401451301309898
Jun-24S589594165151150111111
Sep-24S5075151431281279595
Dec-24S642652201186185137137
Mar-25S650660209193191142142
Jun-25S602611181164163122122
Sep-25S588603194175174130130
Dec-25S673687245226224150150